This webinar looked into planned and ongoing experimental medicine trials for the development of HIV vaccines. Strategy, products and trials design were reviewed and discussed with the aim to identify most promising areas for development.
Speakers and panelists:
• Chair: Nina Russell, the Bill & Melinda Gates Foundation, USA
• Bill Schief, Professor, Department of Immunology and Microbiology, Scripps, USA.
• Robin Shattock, Professor of Mucosal Infection and Immunity, Imperial College London, UK
• Jim Kublin, Executive Director, HIV Vaccine Trials Network, USA
• Ansuya Naidoo, Medical Director, IAVI, South Africa
• Brett Leav, Vice President, Clinical Development, Public Health Vaccines, Moderna, USA
• Stacey Hannah, Director of Research Engagement, AVAC, USA
• Ann Arvin, Senior Vice President, VIR Biotechnology, USA
The webinar included a presentation, a panel discussion and a Q&A.